DDX3X and neoplasm: In particular, in the last few years, a growing number of studies demonstrated a role of the DEAD-box RNA helicase DDX3X in different mechanisms related to tumor proliferation, including cell cycle progression, apoptosis, hypoxia response, and migration, further corroborating its suitability as an anticancer drug target [9,10,11].